Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell laboratories, inc. - bromadiolone - bait - bromadiolone coumarin active 0.05 g/kg - vertebrate poison - building | commercial/industrial premises | domestic and/or public area | farm and/or animal housing | food processing and/or pr - mouse - mus spp. | rat

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x) - polymyxin b 100000 [usp'u] in 1 ml - polytrim® ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus , staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenzae and pseudomonas aeruginosa.*       *efficacy for this organism in this organ system was studied in fewer than 10 infections. polytrim® ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

pacific pharma, inc. - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x) - polymyxin b 10000 [usp'u] in 1 ml - polymyxin b sulfate and trimethoprim ophthalmic solution, usp is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus   epidermidis, streptococcus pneumoniae, streptococcus virida ns , haemophilus influenzae and pseudomonas aeruginosa.* *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution, usp is contraindicated in patients with known hypersensitivity to any of its components.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v), levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - liothyronine 3.1 ug - thyrolar tablets are indicated: - as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. this category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (see warnings ). - as pituitary tsh suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, sub-acute or chronic iymphocytic thyroiditis (hashimoto's), multinodular goiter, and in the management of thyroid cancer. thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adr

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), prednisolone acetate (unii: 8b2807733d) (prednisolone - unii:9phq9y1olm) - gentamicin 3 mg in 1 g - pred-g ® ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphyl

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - gentamicin (unii: t6z9v48ikg) (gentamicin - unii:t6z9v48ikg), prednisolone acetate (unii: 8b2807733d) (prednisolone - unii:9phq9y1olm) - gentamicin 3 mg in 1 ml - pred-g ® suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aur

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

pacific pharma, inc. - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 2.5 mg in 1 ml - levobunolol hcl ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. levobunolol hcl ophthalmic solution is contraindicated in those individuals with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 5 mg in 1 ml - betagan ® ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. betagan ® ophthalmic solution is contraindicated in those individuals with bronchial asthma, or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - eflornithine hydrochloride (unii: 4nh22ndw9h) (eflornithine - unii:zqn1g5v6sr) - eflornithine hydrochloride anhydrous 139 mg in 1 g - vaniqa ®   (eflornithine hydrochloride) cream, 13.9% is indicated for the reduction of unwanted facial hair in women. vaniqa ® has only been studied on the face and adjacent involved areas under the chin of affected individuals. usage should be limited to these areas of involvement. vaniqa ® is contraindicated in patients with a history of sensitivity to any components of the preparation.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

allergan, inc. - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - ursodiol 300 mg - - actigall is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. safety of use of actigall beyond 24 months is not established. - actigall is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - actigall will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. hence, patients with such stones are not candidates for actigall therapy. - patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for actigall therapy. - allergy to bile acids.